The consequences of this elevated expression may be related to the vascular abnormalities observed in SSc, as Sema3E reduces in vitro angiogenesis, and this effect was abrogated after the blocking of PlexinD1, the receptor of Sema3E. Here, SEMA3E is linked to systemic sclerosis.